Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl

Wed, 12th Jul 2023 09:27

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

JPMorgan cuts Intertek price target to 4,400 (4,500) pence - 'neutral'

----------

UBS raises AstraZeneca to 'buy' (neutral) - price target 13,000 (12,500) pence

----------

RBC cuts Bunzl to 'underperform' (sector perform) - price target 2,550 (2,850) pence

----------

Deutsche Bank cuts International Consolidated Airlines to 'hold' (buy) - price target 165 (200) pence

----------

Barclays raises Hargreaves Lansdown target to 1,230 (1,190) pence - 'overweight'

----------

Jefferies cuts Prudential price target to 1,955 (2,020) pence - 'buy'

----------

JPMorgan raises London Stock Exchange price target to 9,967 (9,900) pence - 'overweight'

----------

FTSE 250

----------

Deutsche Bank cuts Wizz Air price target to 2,850 (3,700) pence - 'hold'

----------

Deutsche Bank cuts Wizz Air price target to 2,850 (3,700) pence - 'hold'

----------

Bank of America raises Wizz Air price target to 4,300 (4,200) pence - 'buy'

----------

Bank of America raises easyJet price target to 470 (460) pence - 'underperform'

----------

Deutsche Bank cuts easyJet price target to 585 (635) pence - 'buy'

----------

Barclays cuts Quilter price target to 75 (80) pence - 'underweight'

----------

Barclays raises Hikma Pharmaceutical target to 1,800 (1,700) pence - 'equal weight'

----------

SMALL CAP

----------

Deutsche Bank cuts Forterra target to 214 (245) pence - 'buy'

----------

Berenberg cuts Forterra price target to 210 (250) pence - 'hold'

----------

Deutsche Bank cuts Ryanair price target to 21 (22.50) EUR - 'buy'

----------

Barclays cuts EnQuest price target to 22 (36) pence - 'equal weight'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

15 Apr 2024 09:49

LONDON BROKER RATINGS: UBS raises Crest Nicholson; Stifel cuts CRH

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

26 Mar 2024 09:40

LONDON BROKER RATINGS: Dr Martens cut to 'sell'; BofA likes Tullow

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

25 Mar 2024 10:19

LONDON BROKER RATINGS: SocGen raises Sage; Numis cuts Virgin Money

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of in...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.